Unknown PHASE2 INTERVENTIONAL 2-arm NCT01206946

Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants

Effect of Antenatal Steroids for Women at Risk of Late Preterm Delivery on Neonatal Respiratory Morbidity

Sponsor: American University of Beirut Medical Center

Conditions Respiratory Distress Syndrome, Newborn Transient Tachypnea of the Newborn

Interventions Betamethasone Normal Saline

Updated 5 times since 2017 Last updated: Jun 22, 2011 Started: Sep 30, 2010 Primary completion: Sep 30, 2013 Completion: Sep 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Respiratory Distress Syndrome, Newborn and Transient Tachypnea of the Newborn, this trial is ongoing. The trial is conducted by American University of Beirut Medical Center and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American University of Beirut Medical Center

Data source: American University of Beirut Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beirut, Lebanon